Back to search

Peptide record

TPDB15826

Antibacterial Anticancer Toxicity modified_plain modified
7 source-reported length (unverified)
Basic Information
TPDB15826
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
dbAMP Peptipedia
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide record curated from dbAMP and Peptipedia, without an available 3D structural model. Source-reported length: 7 (unverified).
Modified, details unspecified
Sequence
XXLXAXX

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
7 source-reported length (unverified)
Evidence Records 4 records
Evidence 1 Activity

Activity

IC50
Toxicity
50 µM
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: HL-7702 (L02): IC50>50µM HUVEC: IC50>50µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Nat Commun. 2017 Aug 30 8(1):391.
Evidence 2 Activity

Activity

IC50
Toxicity
24.6 µM
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: HL-7702 (L02): IC50=24.6 µM HUVEC: IC50=18.6 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Nat Commun. 2017 Aug 30 8(1):391.
Evidence 3 Activity

Activity

IC50
Toxicity
7.4 µM
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: HL-7702 (L02): IC50=7.4 µM HUVEC: IC50=33.8 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Nat Commun. 2017 Aug 30 8(1):391.
Evidence 4 Activity

Activity

IC50
Toxicity
14.9 µM
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: HL-7702 (L02): IC50=14.9 µM HUVEC: IC50=18.6 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Nat Commun. 2017 Aug 30 8(1):391.